Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-19-002032
Filing Date
2019-07-23
Accepted
2019-07-23 09:00:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d12126cat_07232019.htm SC 13D 202206
2 LETTER TO THE BOARD, DATED JULY 22, 2019 ex991to13d12126cat_07232019.htm EX-99.1 11733
3 JOINT FILING AGREEMENT ex992to13d12126cat_07232019.htm EX-99.2 7887
  Complete submission text file 0000921895-19-002032.txt   223146
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 19966866
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9777 PYRAMID COURT SUITE 100 ENGLEWOOD CO 80112
Business Address
SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: SC 13D